Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Korman, Alan"" wg kryterium: Autor


Wyświetlanie 1-16 z 16
Tytuł:
Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
Autorzy:
Selby MJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Engelhardt JJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Johnston RJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Lu LS; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Han M; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Thudium K; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Yao D; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Quigley M; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Valle J; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Wang C; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Chen B; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Cardarelli PM; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Blanset D; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Korman AJ; Bristol-Myers Squibb, Redwood City, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Sep 09; Vol. 11 (9), pp. e0161779. Date of Electronic Publication: 2016 Sep 09 (Print Publication: 2016).
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy*
Antibodies, Monoclonal/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Melanoma/*drug therapy
Animals ; Antibodies, Monoclonal/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; CTLA-4 Antigen/antagonists & inhibitors ; CTLA-4 Antigen/metabolism ; Cell Line, Tumor ; Cells, Cultured ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/therapy ; Combined Modality Therapy ; Disease Models, Animal ; Female ; Humans ; Ipilimumab ; Lymphocytes/immunology ; Lymphocytes/metabolism ; Macaca fascicularis ; Melanoma/metabolism ; Melanoma/therapy ; Mice ; Mice, Inbred C57BL ; Nivolumab ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/metabolism ; T-Lymphocytes, Regulatory/metabolism
Czasopismo naukowe
Tytuł:
Evolving synergistic combinations of targeted immunotherapies to combat cancer.
Autorzy:
Melero I; Centro de Investigación Médica Aplicada (CIMA) and Clínica Universitaria, Avenida Pío XII, 55 E-31008, Universidad de Navarra, Pamplona, Spain.
Berman DM; Bristol-Myers Squibb, 3551 Lawrenceville Princeton, New Jersey 08648, USA.
Aznar MA; Centro de Investigación Médica Aplicada (CIMA) and Clínica Universitaria, Avenida Pío XII, 55 E-31008, Universidad de Navarra, Pamplona, Spain.
Korman AJ; Bristol-Myers Squibb Biologics Discovery California, 700 Bay Road, Redwood City, California 94063, USA.
Pérez Gracia JL; Centro de Investigación Médica Aplicada (CIMA) and Clínica Universitaria, Avenida Pío XII, 55 E-31008, Universidad de Navarra, Pamplona, Spain.
Haanen J; The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Nature reviews. Cancer [Nat Rev Cancer] 2015 Aug; Vol. 15 (8), pp. 457-72.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunotherapy*
Neoplasms/*therapy
Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Biomarkers, Tumor/metabolism ; Clinical Trials as Topic ; Combined Modality Therapy ; Humans ; Molecular Targeted Therapy ; Neoplasms/immunology ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł:
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.
Autorzy:
Gubin MM; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Zhang X; Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Schuster H; Department of Immunology, Institute of Cell Biology, and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tübingen, Auf der Morgenstelle 15, 72076 Tübingen, Germany.
Caron E; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland.
Ward JP; 1] Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA [2] Department of Medicine, Division of Oncology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Noguchi T; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Ivanova Y; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Hundal J; The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA.
Arthur CD; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Krebber WJ; ISA Therapeutics B.V., 2333 CH Leiden, The Netherlands.
Mulder GE; ISA Therapeutics B.V., 2333 CH Leiden, The Netherlands.
Toebes M; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Vesely MD; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Lam SS; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Korman AJ; Bristol-Myers Squibb, 700 Bay Road, Redwood City, California 94063, USA.
Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Sharpe AH; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Pearce EL; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Schumacher TN; Division of Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Aebersold R; 1] Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland [2] Faculty of Science, University of Zurich, Zurich, 8093 Zurich, Switzerland.
Rammensee HG; Department of Immunology, Institute of Cell Biology, and German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Tübingen, Auf der Morgenstelle 15, 72076 Tübingen, Germany.
Melief CJ; 1] ISA Therapeutics B.V., 2333 CH Leiden, The Netherlands [2] Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.
Mardis ER; 1] The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St Louis, Missouri 63108, USA [2] Department of Genetics, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Gillanders WE; Department of Surgery, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Artyomov MN; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Schreiber RD; Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, Missouri 63110, USA.
Pokaż więcej
Źródło:
Nature [Nature] 2014 Nov 27; Vol. 515 (7528), pp. 577-81.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunotherapy*
Antibodies, Monoclonal/*therapeutic use
Antigens, Neoplasm/*genetics
Antigens, Neoplasm/*immunology
CD8-Positive T-Lymphocytes/*immunology
Cancer Vaccines/*therapeutic use
Cell Cycle Checkpoints/*immunology
Sarcoma/*therapy
Animals ; Epitopes/genetics ; Male ; Mice ; Sarcoma/immunology ; Vaccines, Synthetic/therapeutic use
Czasopismo naukowe
Tytuł:
Workshop on immunotherapy combinations. Society for Immunotherapy of Cancer annual meeting Bethesda, November 3, 2011.
Autorzy:
Martinez Forero I; Centro de Investigacion Medica Aplicada, Universidad de Navarra, Avda Pio XII, 55, 31008 Pamplona, Spain.
Okada H
Topalian SL
Gajewski TF
Korman AJ
Melero I
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2012 May 28; Vol. 10, pp. 108. Date of Electronic Publication: 2012 May 28.
Typ publikacji:
Congress
MeSH Terms:
Societies, Medical*
Immunotherapy/*methods
Neoplasms/*immunology
Neoplasms/*therapy
Animals ; Antibodies, Monoclonal/immunology ; Cancer Vaccines/immunology ; Cancer Vaccines/therapeutic use ; Combined Modality Therapy ; Humans ; Immune System/immunology ; Immune System/pathology ; Mice ; Neoplasms/prevention & control
Tytuł:
Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011
Autorzy:
Forero Ivan
Okada Hideho
Topalian Suzanne L
Gajewski Thomas F
Korman Alan J
Melero Ignacio
Pokaż więcej
Temat:
Immunotherapy
Combination immunotherapy
Cancer vaccines
Chemotherapy
Anti-CTLA4
Anti-PD/PD-L1
Medicine
Źródło:
Journal of Translational Medicine, Vol 10, Iss 1, p 108 (2012)
Opis pliku:
electronic resource
Relacje:
http://www.translational-medicine.com/content/10/1/108; https://doaj.org/toc/1479-5876
Dostęp URL:
https://doaj.org/article/fe5b7679619f47b881c2c4913a1a2d01  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients.
Autorzy:
Colston, Elizabeth
Grasela, Dennis
Gardiner, David
Bucy, R. Pat
Vakkalagadda, Blisse
Korman, Alan J.
Lowy, Israel
Pokaż więcej
Temat:
LYMPHOCYTES
IPILIMUMAB
HIV
IMMUNE response
ADRENOCORTICAL hormones
ANTIRETROVIRAL agents
Źródło:
PLoS ONE; 6/7/2018, Vol. 13 Issue 6, p1-17, 17p
Czasopismo naukowe
Tytuł:
Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
Autorzy:
Selby, Mark J.
Engelhardt, John J.
Johnston, Robert J.
Lu, Li-Sheng
Han, Minhua
Thudium, Kent
Yao, Dapeng
Quigley, Michael
Valle, Jose
Wang, Changyu
Chen, Bing
Cardarelli, Pina M.
Blanset, Diann
Korman, Alan J.
Pokaż więcej
Temat:
IPILIMUMAB
IMMUNOTHERAPY
IN vitro studies
Źródło:
PLoS ONE; 11/18/2016, Vol. 11 Issue 11, p1-3, 3p
Czasopismo naukowe
Tytuł:
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma.
Autorzy:
Wolchok, Jedd D.
Hodi, F. Stephen
Weber, Jeffrey S.
Allison, James P.
Urba, Walter J.
Robert, Caroline
O'Day, Steven J.
Hoos, Axel
Humphrey, Rachel
Berman, David M.
Lonberg, Nils
Korman, Alan J.
Pokaż więcej
Temat:
IPILIMUMAB
DRUG development
IMMUNOTHERAPY
CANCER treatment
MONOCLONAL antibodies
TARGETED drug delivery
IMMUNE response
CLINICAL trials
Źródło:
Annals of the New York Academy of Sciences; Jul2013, Vol. 1291 Issue 1, p1-13, 13p, 2 Diagrams, 2 Charts, 2 Graphs
Czasopismo naukowe
Tytuł:
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
Autorzy:
Gardiner, David
Lalezari, Jay
Lawitz, Eric
DiMicco, Michael
Ghalib, Rheem
Reddy, K. Rajender
Chang, Kyong-Mi
Sulkowski, Mark
Marro, Steven O’
Anderson, Jeffrey
He, Bing
Kansra, Vikram
McPhee, Fiona
Wind-Rotolo, Megan
Grasela, Dennis
Selby, Mark
Korman, Alan J.
Lowy, Israel
Pokaż więcej
Temat:
MONOCLONAL antibodies
CHRONIC hepatitis C
APOPTOSIS
DEATH receptors
GENE expression
LIGANDS (Biochemistry)
T cells
PLACEBOS
Źródło:
PLoS ONE; May2013, Vol. 8 Issue 5, p1-11, 11p
Czasopismo naukowe
    Wyświetlanie 1-16 z 16

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies